Bearish flow noted in Immunovant with 3,253 puts trading, or 1.8x expected. Most active are Sep-23 10 puts and Oct-23 35 calls, with total volume in those strikes near 2,500 contracts. The Put/Call Ratio is 1.78, while ATM IV is up over 10 points on the day. Earnings are expected on November 3rd.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IMVT:
- Immunovant CEO sells $2.2M in common stock
- Immunovant price target raised to $33 from $28 at Citi
- Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2023
- Immunovant reports Q1 EPS (57c), consensus (45c)
- Citi opens ‘positive catalyst watch’ on Immunovant into data